These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Plasma prekallikrein activity in patients with total hip arthroplasty. Hoffmann JJ; Kortmann JH Thromb Haemost; 1987 Dec; 58(4):1040-2. PubMed ID: 3445224 [TBL] [Abstract][Full Text] [Related]
4. [Determination of factor XII and plasma prekallikrein with chromozym PK]. Stürzebecher J; Klessen C; Markwardt F Z Med Lab Diagn; 1982 Oct; 23(5):306-11. PubMed ID: 6924817 [No Abstract] [Full Text] [Related]
5. [Determination of plasma prekallikrein using beta-XIIa (Hageman factor fragment)]. Komiyama Y; Egawa H; Murata K Rinsho Byori; 1984 May; 32(5):558-62. PubMed ID: 6332927 [No Abstract] [Full Text] [Related]
6. Determination of prekallikrein using an amidolytic assay in plasma samples of critically ill patients. Kalter ES; Vlooswijk RA; Bouma BN Acta Chir Scand Suppl; 1982; 509():43-7. PubMed ID: 6962618 [No Abstract] [Full Text] [Related]
7. Assay of Fletcher factor (plasma prekallikrein) using an artificial clotting reagent and a modified chromogenic assay. Soulier JP; Gozin D Thromb Haemost; 1979 Aug; 42(2):538-47. PubMed ID: 505362 [TBL] [Abstract][Full Text] [Related]
8. [A study of coagulation contact factors in hereditary angioneurotic oedema (author's transl)]. Soulier JP; Gozin D; Ollier-Hartmann MP; Hartmann L Nouv Presse Med; 1981 May; 10(20):1627-31. PubMed ID: 6166918 [TBL] [Abstract][Full Text] [Related]
9. Plasma prekallikrein: quantitative determination by direct activation with Hageman factor fragment (beta-XIIa). Alving BM; Tankersley DL; Mason BL J Lab Clin Med; 1983 Feb; 101(2):226-41. PubMed ID: 6549773 [TBL] [Abstract][Full Text] [Related]
10. Enhanced specificity of immunoblotting using radiolabeled antigen overlay: studies of blood coagulation factor XII and prekallikrein in plasma. Lämmle B; Berrettini M; Griffin JH Anal Biochem; 1986 Jul; 156(1):118-25. PubMed ID: 3638135 [TBL] [Abstract][Full Text] [Related]
11. Analyses of factor XII, prekallikrein and kallikrein inhibitory capacity in patients with laboratory signs of DIC. Egberg N; Hellgren M Scand J Clin Lab Invest Suppl; 1985; 178():25-9. PubMed ID: 3867118 [TBL] [Abstract][Full Text] [Related]
12. Proposal for objective evaluation of the performance of various functional APC-resistance tests in genotyped patients. Freyburger G; Javorschi S; Labrouche S; Bernard P Thromb Haemost; 1997 Nov; 78(5):1360-5. PubMed ID: 9408020 [TBL] [Abstract][Full Text] [Related]
13. Hageman factor, high molecular weight kininogen, and prekallikrein in chronic liver disease. Cordova C; Violi F; Alessandri C; Ferro D; Saliola M; Balsano F J Clin Pathol; 1986 Sep; 39(9):1003-5. PubMed ID: 3639088 [TBL] [Abstract][Full Text] [Related]
14. Studies on assays for plasma prekallikrein and for the monitoring of coumarol therapy. Egberg N; Bergström K Haemostasis; 1978; 7(2-3):85-91. PubMed ID: 149049 [TBL] [Abstract][Full Text] [Related]
15. Factors XI and XII and prekallikrein in sick and healthy premature infants. Andrew M; Bhogal M; Karpatkin M N Engl J Med; 1981 Nov; 305(19):1130-3. PubMed ID: 6912944 [No Abstract] [Full Text] [Related]
16. Plasma contact activation and decrease of factor V activity on negatively-charged polyelectrolytes. Boffa MC; Dreyer B; Pusineri C Thromb Haemost; 1984 Feb; 51(1):61-4. PubMed ID: 6719390 [TBL] [Abstract][Full Text] [Related]
17. Prekallikrein deficiency in a family of miniature horses. Turrentine MA; Sculley PW; Green EM; Johnson GS Am J Vet Res; 1986 Nov; 47(11):2464-7. PubMed ID: 3641551 [TBL] [Abstract][Full Text] [Related]
18. [Contact coagulation factors]. Kojima T; Saito H Rinsho Byori; 1987 Apr; Spec No 70():79-87. PubMed ID: 3302400 [No Abstract] [Full Text] [Related]
19. Activated protein C resistance--a major risk factor for thrombosis. Rosén SB; Sturk A Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726 [TBL] [Abstract][Full Text] [Related]